Impact of HIV kick-and-kill therapy on host epigenetic and transcriptional programs in PBMC, and viral rebound after cART interruption
| dc.contributor.author | Oriol-Tordera, Bruna | |
| dc.contributor.author | Esteve-Codina, Anna | |
| dc.contributor.author | Berdasco, María | |
| dc.contributor.author | Gonçalves, Elena | |
| dc.contributor.author | Esteller, Manel | |
| dc.contributor.author | Hanke, Tomá | |
| dc.contributor.author | Moltó, José | |
| dc.contributor.author | Clotet, Bonaventura, 1953- | |
| dc.contributor.author | Calle, María Luz | |
| dc.contributor.author | Combadiere, Behazine | |
| dc.contributor.author | Sànchez, Àlex (Sànchez Pla) | |
| dc.contributor.author | Mothe, Beatriz | |
| dc.contributor.author | Ruiz-Riol, Marta | |
| dc.contributor.author | Brander, Christian | |
| dc.date.accessioned | 2023-05-16T14:18:12Z | |
| dc.date.available | 2023-05-16T14:18:12Z | |
| dc.date.issued | 2021-01-01 | |
| dc.date.updated | 2023-05-16T14:18:12Z | |
| dc.description.abstract | Background: BCN02 was a pilot kick-and-kill clinical trial that combined therapeutic vaccination (MVA.HIVconsv) with the latency reversing agent romidepsin (RMD) followed by a monitored antiretroviral pause (MAP) in 15 early-treated HIV+ individuals (NCT02616874). Out of 12 evaluable participants for an omics subanalysis, 8 participants showed early (pVL > 2000 copies/mL < 4 weeks) and 4 a more delayed viral rebound (pVL > 2000 copies/mL > 4 weeks) in MAP. Systems biology analyses identified epigenetic and molecular mechanisms associated with response to vaccination and RMD and viral rebound kinetics. | |
| dc.format.extent | 3 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 720636 | |
| dc.identifier.issn | 1758-2652 | |
| dc.identifier.uri | https://hdl.handle.net/2445/198070 | |
| dc.language.iso | eng | |
| dc.publisher | BioMed Central | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1002/jia2.25659 | |
| dc.relation.ispartof | Journal of the International AIDS Society, 2021, vol. 24, num. S1, p. 36-38 | |
| dc.relation.uri | https://doi.org/10.1002/jia2.25659 | |
| dc.rights | cc-by (c) Oriol-Tordera, Bruna et al., 2021 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Articles publicats en revistes (Genètica, Microbiologia i Estadística) | |
| dc.subject.classification | VIH (Virus) | |
| dc.subject.classification | Epigenètica | |
| dc.subject.other | HIV (Viruses) | |
| dc.subject.other | Epigenetics | |
| dc.title | Impact of HIV kick-and-kill therapy on host epigenetic and transcriptional programs in PBMC, and viral rebound after cART interruption | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1